Bank of America’s Allena Pharmaceuticals ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,800
| Closed | -$1K | – | 8525 |
|
|
2022
Q2 | $1K | Hold |
5,800
| – | – | ﹤0.01% | 7942 |
|
|
2022
Q1 | $1K | Hold |
5,800
| – | – | ﹤0.01% | 8183 |
|
|
2021
Q4 | $3K | Sell |
5,800
-100
| -2% | -$78 | ﹤0.01% | 7967 |
|
|
2021
Q3 | $5K | Sell |
5,900
-18
| -0.3% | -$18 | ﹤0.01% | 7756 |
|
|
2021
Q2 | $8K | Buy |
5,918
+18
| +0.3% | +$22 | ﹤0.01% | 7361 |
|
|
2021
Q1 | $8K | Buy |
5,900
+3,000
| +103% | +$5K | ﹤0.01% | 7064 |
|
|
2020
Q4 | $4K | Sell |
2,900
-2,500
| -46% | -$3.49K | ﹤0.01% | 6877 |
|
|
2020
Q3 | $8K | Hold |
5,400
| – | – | ﹤0.01% | 6515 |
|
|
2020
Q2 | $9K | Buy |
+5,400
| New | +$9.07K | ﹤0.01% | 6477 |
|
|
2019
Q4 | – | Sell |
-14,854
| Closed | -$59K | – | 7553 |
|
|
2019
Q3 | $59K | Sell |
14,854
-1,562
| -10% | -$6.7K | ﹤0.01% | 6256 |
|
|
2019
Q2 | $67K | Buy |
16,416
+13,353
| +436% | +$73K | ﹤0.01% | 6183 |
|
|
2019
Q1 | $21K | Sell |
3,063
-3,564
| -54% | -$25.8K | ﹤0.01% | 6492 |
|
|
2018
Q4 | $36K | Buy |
6,627
+4,050
| +157% | +$34.9K | ﹤0.01% | 6327 |
|
|
2018
Q3 | $27K | Buy |
2,577
+714
| +38% | +$7.85K | ﹤0.01% | 6419 |
|
|
2018
Q2 | $24K | Buy |
1,863
+1,454
| +356% | +$21K | ﹤0.01% | 6461 |
|
|
2018
Q1 | $4K | Sell |
409
-278
| -40% | -$2.32K | ﹤0.01% | 6820 |
|
|
2017
Q4 | $7K | Buy |
+687
| New | +$8.47K | ﹤0.01% | 6688 |
|
Other funds holding ALNA
Bank of America's ALNA Position: Q3 2022 in Review
Bank of America sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 5,800 shares — an estimated $1K sold.
Bank of America first reported a position in ALNA in Q4 2017 and held it in 17 quarters. The position peaked at $67K in Q2 2019. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.
- Bank of America reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Bank of America sold 5,800 Allena Pharmaceuticals shares in Q3 2022, an estimated $1K.
- Bank of America first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 17 quarters.
- Bank of America's Allena Pharmaceuticals position peaked at $67K in Q2 2019.
- 2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.
Based on Bank of America's 13F filing for Q3 2022, filed 14 Nov 2022.